4 completed, 2 withdrawn, 1 terminated. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Withdrawn 2, Terminated 1 |
| Phase 1 | 3 | Withdrawn 2, Completed 1 |
Follow FS 069: new trials by email Literature Review of FS 069 trials Research Report on FS 069
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound - Intrahepatic Cholangiocarcinoma | Phase 2 | Completed | Thomas Jefferson University | 16 | 2021-12-14 | 2025-10-28 |
| Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging - Hepatocellular Carcinoma | Phase 2 | Completed | Thomas Jefferson University | 104 | 2017-07-01 | 2026-01-02 |
| Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation Optison - Renal Cell Carcinoma | Phase 2 | Completed | Thomas Jefferson University | 53 | 2015-04-23 | 2025-05-04 |
| Contrast-Enhanced Ultrasound in Human Crohn's Disease Contrast Enhanced Ultrasound, Optison - Crohn's Disease | Phase 1 / Phase 2 | Withdrawn | University of Michigan | 2015-02-01 | 2015-06-15 | |
| CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children OPTISON - Vesico-Ureteral Reflux | Phase 1 / Phase 2 | Completed | Kassa Darge | 31 | 2014-07-01 | 2018-11-27 |
| Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease Optison - Carotid Artery Disease | Phase 2 | Terminated | GE Healthcare | 21 | 2011-06-01 | 2014-05-02 |
| Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE) SonoVue, Optison - Coronary Artery Disease | Phase 1 / Phase 2 | Withdrawn | University Hospital, Basel, Switzerland | 2006-08-01 | 2015-03-25 |
Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Carotid Artery Diseases (1) · Cholangiocarcinoma (1) · Coronary Artery Disease (1) · Crohn Disease (1) · Vesico-Ureteral Reflux (1)
Thomas Jefferson University (3) · GE Healthcare (1) · Kassa Darge (1) · University Hospital, Basel, Switzerland (1) · University of Michigan (1)
United States (6)
Andrea Perrone, M.D. (1) · John Eisenbrey, PhD (1) · Kassa Darge, MD, PhD (1) · Manfred D Seeberger, Prof. Dr. (1)
R01CA238241 (1), R21CA259750 (1)